News | April 17, 2026
Moberg Pharma reports 2025 annual results, maintains strong cash position
The company reported net revenue of SEK 13.5 million for the full year 2025
The company reported net revenue of SEK 13.5 million for the full year 2025
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
To boost compostable packaging, resin innovation, and supply chain speed
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Subscribe To Our Newsletter & Stay Updated
